SCHEMBL8770160

SCHEMBL8770160

ClCCCCOc1ccc(C(=C(Cl)c2ccccc2)c2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.55
▸ PTGS1 P23219 3/20 0.55
▸ SLC6A2 P23975 3/20 0.55
▸ SLC6A3 Q01959 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ KCNH2 Q12809 2/20 0.55
▸ EBP Q15125 2/20 0.55
▸ SIGMAR1 Q99720 2/20 0.55
▸ CHRM2 P08172 2/20 0.55
▸ ADRA2A P08913 2/20 0.55
▸ ADORA3 P0DMS8 2/20 0.55
▸ CHRM1 P11229 2/20 0.55
▸ SLC6A4 P31645 2/20 0.55
▸ DRD3 P35462 2/20 0.55
▸ HTR6 P50406 2/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ HTT P42858 2/20 0.55
▸ IDH1 O75874 1/20 0.55
▸ EGFR P00533 1/20 0.55
▸ ERBB2 P04626 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8639615 0.92 ESR1 (0.63) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8613926 0.92 ESR1 (0.63) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8639618 0.92 ESR1 (0.63) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8639612 0.92 ESR1 (0.63) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8644016 0.90 ESR1 (0.62) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8644018 0.90 ESR1 (0.62) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8644014 0.90 ESR1 (0.62) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8770194 0.89 ESR1 (0.58) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8642207 0.89 ESR1 (0.58) ESR1PTGS1SLC6A2SLC6A3KMT2A
SCHEMBL8656245 0.82 ESR1 (0.61) ESR1PTGS1SLC6A2SLC6A3KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1167437-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL INC (US) 1997-12-10 — — CN disclosed
US-5693674-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-12-02 — — US disclosed
US-5691384-A Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis HOECHST MARION ROUSSEL, INC. (US) 1997-11-25 — — US disclosed
EP-0794771-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1997-09-17 — — EP disclosed
WO-1996016646-A1 METHOD OF USING TRIARYL-ETHYLENE DERIVATIVES IN THE TREATMENT AND PREVENTION OF OSTEOPOROSIS HOECHST MARION ROUSSEL, INC. (US) 1996-06-06 — — WO disclosed
Send feedback